Genome Editing Market to Reach $50.7 Billion by 2035

Genome editing market was valued at $13.2 billion in 2025 and is expected to reach $50.7 billion by 2035, registering a CAGR of 14.5% during the forecast period from 2026 to 2035. The global genome editing market is being propelled by the widespread adoption of CRISPR?based technologies for both therapeutic development and foundational research, as these tools deliver precise, efficient genomic alterations that were previously unattainable. This driver has a significant impact on the market’s trajectory because CRISPR systems are increasingly deployed in clinical trial programs, preclinical disease models, and research applications that support drug discovery and genetic disease correction. Key industry participants and research institutions are scaling CRISPR platforms to accelerate pipeline progression and validate new therapeutic modalities. Adoption beyond human therapeutics into agricultural and biological research further broadens commercial opportunities, strengthening revenue streams across segments. The convergence of technological capability and expanding use cases is reinforcing investor confidence and commercial commitment in genome editing innovation.

Browse the full report description of “Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR-Based Genome Editing, TALEN-Based Genome Editing, Zinc Finger Nucleases (ZFNs), and Other Technologies), by Application (Cell Line Engineering, Genetic Engineering (Plant and Animal), Gene Therapy, Drug Discovery and Development, and Other Applications), and by End Users (Biotechnology and Pharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, and Other End Users), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/genome-editing-market

Supporting Data and Key Findings

• At least 114 registered clinical trials involving CRISPR therapeutics and interventions were identified across major international trial registries as of mid?2024, indicating active clinical development activity linked directly to CRISPR applications.
• Analysis of genome?edited crop studies showed that CRISPR/Cas systems accounted for 95?% of reported techniques, underscoring the dominance of CRISPR in research and applied editing workflows.
• The prominent application of CRISPR in diverse research domains highlights its versatility, from genetic disorder investigation to precision trait engineering in plants.
• Widespread scientific publication and patent activity associated with CRISPR and derivative systems reflect robust knowledge creation and commercial interest in the technology.
• The prevalence of CRISPR tools in registered clinical protocols shows that translational research is advancing toward therapeutic implementation at scale.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Technology
  • Application
  • End Users
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape – CRISPR Therapeutics AG, Editas Medicine, Inc., Intellia Therapeutics, Inc., Merck KGaA, Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Genome Editing Market Report Segment

By Technology

• CRISPR-Based Genome Editing
• TALEN-Based Genome Editing
• Zinc Finger Nucleases (ZFNs)
• Other Technologies

By Application

• Cell Line Engineering
• Genetic Engineering (Plant and Animal)
• Gene Therapy
• Drug Discovery and Development
• Other Applications

By End Users

• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Academic and Research Institutes
• Other End Users

Global Genome Editing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/genome-editing-market